<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-65746</identifier>
<setSpec>0004-2927</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Over recent years new concepts in nutrition have been arising in consequence of some of the negative aspects of modern lifestyles in today&#146;s highly developed societies. This has brought about the appearance of the term &#147;functional foods&#148;, which can be defined as a modified foodstuff or ingredient that can promote better health benefits than those offered by traditional foods. Probiotic bacteria have been included within the concept of functional foods, given that there is sufficient evidence to suggest their effectiveness in combating certain pathologies. Furthermore, numerous experimental studies have identified the action mechanisms that facilitate the development of the most effective microorganisms, whileat the same time establishing the limits of their effectiveness (AU)</dc:description>
<dc:creator>Zarzuelo, A</dc:creator>
<dc:creator>Camuesco, D</dc:creator>
<dc:creator>Arribas, B</dc:creator>
<dc:creator>Rodríguez, ME</dc:creator>
<dc:creator>Gálvez, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En los últimos años han comenzado a desarrollarse nuevos conceptos en nutrición como fruto de la preocupación por una elevada calidad de vida de la sociedad desarrollada. Esto ha promovido la aparición del término &#147;alimento funcional&#148;, que se puede definir como aquel producto, alimento modificado o ingrediente alimentario, que puede proveer beneficios a la salud superiores a los ofrecidos por los alimentos tradicionales. Las bacterias probióticas quedan incluidas dentro del campo de los alimentos funcionales, existiendo evidencias de su eficacia en ciertas patologías, y suficientes estudios experimentales en otras para justificar posibles mecanismos de acción que faciliten el desarrollo de microorganismos más efectivos, así como para definir los límites de su efectividad (AU)</dc:description>
<dc:source>Ars pharm;49(1): 5-30, 2008. ilus</dc:source>
<dc:identifier>ibc-65746</dc:identifier>
<dc:subject>^d7954^s29165</dc:subject>
<dc:subject>^d7291^s22031</dc:subject>
<dc:subject>^d52503^s22031</dc:subject>
<dc:subject>^d12225</dc:subject>
<dc:subject>^d7954^s22031</dc:subject>
<dc:subject>^d33510^s22002</dc:subject>
<dc:subject>^d33510^s22079</dc:subject>
<dc:subject>^d33510^s22078</dc:subject>
<dc:subject>^d33510^s22044</dc:subject>
<dc:subject>^d33510^s22065</dc:subject>
<dc:subject>^d52503^s22019</dc:subject>
<dc:subject>^d33510^s22073</dc:subject>
<dc:subject>^d7571^s22031</dc:subject>
<dc:type>article</dc:type>
<dc:date>200800</dc:date>
</metadata>
</record>
</ibecs-document>
